SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-086902
Filing Date
2021-06-29
Accepted
2021-06-29 17:00:49
Documents
5
Period of Report
2021-06-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2120834d1_8k.htm 8-K 25642
2 EXHIBIT 3.1 tm2120834d1_ex3-1.htm EX-3.1 37613
3 EXHIBIT 3.2 tm2120834d1_ex3-2.htm EX-3.2 155466
4 EXHIBIT 99.1 tm2120834d1_ex99-1.htm EX-99.1 7205
5 EXHIBIT 99.2 tm2120834d1_ex99-2.htm EX-99.2 6593
  Complete submission text file 0001104659-21-086902.txt   233959
Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Filer) CIK: 0001736243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40536 | Film No.: 211058967
SIC: 2834 Pharmaceutical Preparations